![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2020
Kirchner, Sophie K.; Ozkan, Selen; Musil, Richard; Spellmann, Ilja; Kannayian, Nirmal; Falkai, Peter; Rossner, Moritz und Papiol, Sergi
(2020):
Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 270, Nr. 4: S. 425-431
Hasan, Alkomiet; Roeh, Astrid; Leucht, Stefan; Langguth, Berthold; Hansbauer, Maximilian; Oviedo-Salcedo, Tatiana; Kirchner, Sophie K.; Papazova, Irina; Loehrs, Lisa; Wagner, Elias; Maurus, Isabel; Strube, Wolfgang; Rossner, Moritz J.; Wehr, Michael C.; Bauer, Ingrid; Heres, Stephan; Leucht, Claudia; Kreuzer, Peter M.; Zimmermann, Stephanie; Schneider-Axmann, Thomas; Goerlitz, Thomas; Karch, Susanne; Egert-Schwender, Silvia; Schossow, Beate; Rothe, Philipp und Falkai, Peter
(2020):
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
In: Contemporary Clinical Trials Communications, Bd. 17, 100537
2019
Roeh, Astrid; Kirchner, Sophie K.; Malchow, Berend; Maurus, Isabel; Schmitt, Andrea; Falkai, Peter und Hasan, Alkomiet
(20. März 2019):
Depression in Somatic Disorders: Is There a Beneficial Effect of Exercise?
In: Frontiers in Psychiatry, Bd. 10, 141
[PDF, 1MB]
2018
Kirchner, Sophie K.; Roeh, Astrid; Nolden, Jana und Hasan, Alkomiet
(2018):
Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review.
In: npj Schizophrenia, Bd. 4, 20
[PDF, 790kB]